Abstract

The goal of this research is to develop 64Cu radiolabeled somatostatin-receptor ligands for position emission tomography (PET) imaging and radiotherapy of cancer. Copper-64 radiopharmaceuticals have been used as PET imaging agents for various diseases because of the favorable decay characteristics of 64Cu (t1/2 = 12.7 h; β+ (17.8%); β- (38.4%)).

Committee Chair

Carolyn J. Anderson

Committee Members

William E. Buhro, Sophia E. Hayes, Suzanne E. Lapi, Liviu M. Mirica, Buck E. Rogers

Comments

Permanent URL: https://doi.org/10.7936/K76M34RZ

Degree

Doctor of Philosophy (PhD)

Author's Department

Chemistry

Author's School

Graduate School of Arts and Sciences

Document Type

Dissertation

Date of Award

Winter 12-15-2010

Language

English (en)

Available for download on Monday, December 15, 2110

Included in

Chemistry Commons

Share

COinS